Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
Submitted by
admin
on February 10, 2015 - 8:41am
Source:
WSJ Pharmalot
News Tags:
patents
Big Pharma
Abilify
Amgen
AstraZeneca
Biogen Idec
Bristol-Myers Squibb
Crestor
Eli Lilly
Gilead Sciences
GSK
Harvoni
Hospira
Merck
Novo Nordisk
Pfizer
Sovaldi
Tecfidera
Headline:
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
Do Not Allow Advertisers to Use My Personal information
